A COMPARATIVE STUDY ON THE SAFETY AND EFFICACY OF TOPICAL BIMATOPROST WITH TIMOLOL MALEATE IN GLAUCOMA PATIENTS

被引:0
|
作者
Polagani, Padma [1 ]
Maddikunta, Sridhar Venkat [2 ]
Balakrishna, Namala [2 ]
Kondaveti, Souris [2 ]
机构
[1] Kakatiya Med Coll, Dept Pharmacol, Warangal, Telangana, India
[2] Osmania Med Coll & Hosp, Dept Pharmacol, Hyderabad, Telangana, India
来源
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS | 2016年 / 5卷 / 46期
关键词
IOP; PACG; POAG; Bimatoprost; Timolol Maleate;
D O I
10.14260/jemds/2016/670
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Glaucoma is a group of disorders characterized by increase in Intraocular Pressure OOP), which can damage the optic nerve and if untreated can lead to gradual peripheral vision loss and irreversible blindness. Glaucoma classified into primary and secondary glaucoma. Primary glaucoma has two types Primary Open Angle Glaucoma (POAG) and Primary Angle Closure Glaucoma (PACG). Glaucoma is the second leading cause of blindness. Worldwide, it is estimated that about 66.8 million people have visual impairment from glaucoma with 6.8 million suffering from blindness. AIMS AND OBJECTIVE To assess the level of IOP reduction of bimatoprost with timolol maleate and its statistical analysis. To compare the IOP lowering efficacy of bimatoprost with timolol maleate. To study the adverse drug reaction profiles of both the drugs. MATERIALS AND METHODS This study was designed to compare the efficacy and safety of topical anti-glaucoma drugs, Bimatoprost (0.03%) and Timolol maleate (0.5%) in patients with POAG attending at Regional Eye Hospital, Warangal. RESULTS In this study mean reduction of IOP at 2 wks., 6 wks., 12 wks., 24 wks. were 6.60 mmHg (23.21%), 9.6 mmHg (33.76%), 10.00 mmHg (38.68%), 11.20 mmHg (39.39%) for Bimatoprost and 4.20 mmHg (15.07%), 6.24% mmHg (23.39%), 7.36 mmHg (25.91%) and 7.64 mmHg (26.56%) for Timolol group respectively. STATISTICAL METHOD Student's 't' test was used for analysis of results. CONCLUSION Bimatoprost 0.03% ophthalmic solution was highly efficacious, well tolerated, systemically safe and minimal ocular side effects and less drug withdraw. It can be used as first line therapy to treat cases of POAG to reduce IOP. The only limitation for its use is regarding its cost. The topical bimatoprost preparations are expensive when compared to the topical Timolol maleate. But considering the reduction in IOP, the modifiable factor for preventing the progression of optic nerve head damage and preservation of visual function hence increase the quality of vision and life.
引用
收藏
页码:2974 / 2979
页数:6
相关论文
共 50 条
  • [21] Bimatoprost and Bimatoprost/Timolol Fixed Combination in Patients with Open-Angle Glaucoma and Ocular Hypertension
    Katsanos, Andreas
    Dastiridou, Anna I.
    Fanariotis, Michael
    Kotoula, Maria
    Tsironi, Evangelia E.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (01) : 67 - 71
  • [22] Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma
    Lorenz, Katrin
    Pfeiffer, Norbert
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (15) : 2255 - 2262
  • [23] Efficacy and safety of latanoprost/timolol maleate fixed combination verses timolol maleate and brimonidine given twice daily
    Stewart, JA
    Day, DG
    Sharpe, ED
    Stewart, WC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U969 - U969
  • [24] Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily
    Stewart, WC
    Stewart, JA
    Day, D
    Sharpe, ED
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2003, 81 (03): : 242 - 246
  • [25] Efficacy and safety of fixed-combination bimatoprost/timolol ophthalmic solution
    Moon, Suk Bae
    Han, Sang Beom
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1069 - 1070
  • [26] Efficacy and safety of bimatoprost in glaucoma and ocular hypertension in non-responder patients
    Brennan, Nicholas
    Dehabadi, Mohammad H.
    Nair, Sandhya
    Quartilho, Ana
    Bunce, Catey
    Reekie, Ian
    Obikpo, Raal
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (08) : 1251 - 1254
  • [27] Efficacy and safety of bimatoprost in glaucoma and ocular hypertension in non-responder patients
    Nicholas Brennan
    Mohammad H Dehabadi
    Sandhya Nair
    Ana Quartilho
    Catey Bunce
    Ian Reekie
    Raal Obikpo
    International Journal of Ophthalmology, 2017, 10 (08) : 1251 - 1254
  • [28] Efficacy and safety of bimatoprost in patients with uncontrolled glaucoma-as alternative to filtration surgery
    Vetrugno, M
    Sborgia, C
    Balestrazzi, E
    Bianchi, C
    Caporossi, A
    Nardi, M
    Rapisarda, A
    Tassinari, G
    Zeppa, L
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2005, 15 (04) : 477 - 481
  • [29] Efficacy of Bimatoprost Plus Timolol Fixed Combination in Open Angle Glaucoma Patients Previously Treated with Dorzolamide Plus Timolol Fixed Combination
    Sacchi, Matteo
    Specchia, Claudia
    Williams, Susan E.
    Villani, Edoardo
    Nucci, Paolo
    CURRENT EYE RESEARCH, 2016, 41 (11) : 1433 - 1437
  • [30] Topical Timolol Maleate for Superficial Infantile Hemangiomas: An Observational Study
    Xu, Da-Peng
    Cao, Rong-Yu
    Tong, Shuang
    Xue, Lei
    Sun, Ning-Ning
    Wang, Xu-Kai
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2015, 73 (06) : 1089 - 1094